Telos Capital Management Inc. Sells 1,378 Shares of Aflac Incorporated (NYSE:AFL)

Telos Capital Management Inc. lowered its position in Aflac Incorporated (NYSE:AFLFree Report) by 8.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 15,677 shares of the financial services provider’s stock after selling 1,378 shares during the period. Telos Capital Management Inc.’s holdings in Aflac were worth $1,753,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. Dimensional Fund Advisors LP grew its holdings in shares of Aflac by 6.3% in the second quarter. Dimensional Fund Advisors LP now owns 4,807,079 shares of the financial services provider’s stock worth $429,319,000 after acquiring an additional 285,576 shares during the period. APG Asset Management N.V. lifted its position in Aflac by 1.3% during the second quarter. APG Asset Management N.V. now owns 2,429,316 shares of the financial services provider’s stock valued at $202,437,000 after purchasing an additional 31,752 shares in the last quarter. Guinness Asset Management LTD lifted its position in Aflac by 3.8% during the third quarter. Guinness Asset Management LTD now owns 2,276,325 shares of the financial services provider’s stock valued at $254,382,000 after purchasing an additional 83,289 shares in the last quarter. ProShare Advisors LLC lifted its position in Aflac by 5.6% during the second quarter. ProShare Advisors LLC now owns 2,220,125 shares of the financial services provider’s stock valued at $198,279,000 after purchasing an additional 117,504 shares in the last quarter. Finally, Truist Financial Corp lifted its position in Aflac by 26.6% during the second quarter. Truist Financial Corp now owns 1,929,662 shares of the financial services provider’s stock valued at $172,338,000 after purchasing an additional 405,847 shares in the last quarter. Institutional investors own 67.44% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. UBS Group lifted their target price on Aflac from $84.00 to $109.00 and gave the company a “neutral” rating in a research report on Wednesday, August 14th. Evercore ISI lifted their target price on Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a research report on Thursday, September 26th. Piper Sandler lifted their target price on Aflac from $114.00 to $122.00 and gave the company an “overweight” rating in a research report on Wednesday, October 2nd. Wells Fargo & Company boosted their price objective on Aflac from $90.00 to $106.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. Finally, Barclays started coverage on Aflac in a research report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $97.53.

View Our Latest Analysis on Aflac

Insider Activity

In other news, Director Thomas J. Kenny sold 2,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Insiders own 0.90% of the company’s stock.

Aflac Trading Down 1.5 %

Shares of NYSE AFL opened at $112.75 on Tuesday. The business’s 50 day moving average is $109.63 and its two-hundred day moving average is $96.18. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.10. Aflac Incorporated has a 1-year low of $75.07 and a 1-year high of $115.50. The stock has a market capitalization of $64.07 billion, a P/E ratio of 12.44, a PEG ratio of 2.62 and a beta of 0.95.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.60 by $0.23. The company had revenue of $5.14 billion for the quarter, compared to analysts’ expectations of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The firm’s revenue for the quarter was down .7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.58 earnings per share. As a group, research analysts expect that Aflac Incorporated will post 6.76 EPS for the current year.

Aflac Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Stockholders of record on Wednesday, August 21st were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Wednesday, August 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.77%. Aflac’s dividend payout ratio is 22.08%.

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Recommended Stories

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.